Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Research
Return to: PBR Home | Contract Research & Services | Contract Research

Contract Research

Redx Pharma secures $1m grant for bacteria research Redx Pharma has secured a $1m grant fromCARB-X, one of the world’s largest public-private partnerships, launched in July 2016 to speed up global antibacterial innovation and research.
Contract Research & Services > Contract Research > News
Bristol-Myers Squibb, CytomX extend cancer collaboration By PBR Staff Writer
Bristol-Myers Squibb (BMS) is paying CytomX Therapeutics $200m upfront to add up to eight new candidates to their existing Probody therapeutics collaboration.
Contract Research & Services > Contract Research > News Novimmune, LegoChem to collaborate on antibody drug conjugate research Swiss biotech company Novimmune and South Korea based LegoChem Biosciences (LCB) have entered into a research collaboration to evaluate an antibody drug conjugate candidate.
Contract Research & Services > Contract Research > News
See more Contract Research news

Latest Contract Research News and Insight

View all Contract Research news or find news targeted to your interests
Redx Pharma secures $1m grant for bacteria research
Redx Pharma has secured a $1m grant fromCARB-X, one of the world’s largest public-private partnerships, launched in July 2016 to speed up global antibacterial innovation and research.
Contract Research & Services > Contract Research > News
Bristol-Myers Squibb, CytomX extend cancer collaboration
By PBR Staff Writer
Bristol-Myers Squibb (BMS) is paying CytomX Therapeutics $200m upfront to add up to eight new candidates to their existing Probody therapeutics collaboration.
Contract Research & Services > Contract Research > News
A Survival Guide to Temperature Data in Life Sciences, by Almac
| By Almac
Regulations continue to evolve globally within the distribution arena of the Life Sciences industry. Good Distribution Practice of Medicinal Products for Human Use (2013/C 343/01)1 as well as Good Distribution Practices Supply Chain Integrity2 has made the most significant impact. There is an increased focus on companies being able to prove the quality and integrity of their drug product throughout the entire supply chain. The industry is facing stricter compliance demands from regulations and regulatory agencies are not always given clear guidance.
Contract Research & Services > Contract Research > White Papers
Almac: Changing the Dynamics of Temperature Controlled Shipping Solutions
| By Almac
In the typical clinical trial today, the cost of shipping and distributing supplies accounts for approximately 60 percent of the overall clinical supply chain. And when the cost of product spoilage from temperature excursions is added into the mix, it is no wonder that pharmaceutical companies, Clinical Research Organizations (CROs), and logistics vendors are all eagerly searching for efficiencies and ways to carve costs out of the process.
Contract Research & Services > Contract Research > White Papers
Almac Explores Interactive Response Technology: An Untapped Source of Historical and Real-Time Data for Risk-Based Monitoring
| By Almac
Risk-based monitoring has attracted the support of a diverse group of organisations in recent years. Regulators have released guidance encouraging the use of risk-based approaches to clinical trial quality, vendors have created technologies to support such methods, and large pharma companies have pooled their resources to drive adoption. Yet, despite this flurry of activity, the industry has overlooked a potentially useful source of real-time and historical data.
Contract Research & Services > Contract Research > White Papers
Almac Presents Modern Perspectives on Peptide Synthesis, an Introduction
| By Almac
The complexity of synthetic peptide products, whether as reagents used in research or as therapeutic APIs, is increasing. As researchers understand more about the biochemical systems which are targeted, and invent ever more sophisticated products, manufacturing methods must keep pace. We look in this article at a number of challenging product classes, the specific problems they present, and potential solutions: Long peptides; Multi-peptide cocktails; Site-specifically modified products.
Contract Research & Services > Contract Research > White Papers
Almac Presents selectAZymeTM for Effective Biocatalysis Solutions
Almac’s biocatalysis expertise ranges from enzyme discovery, evolution and enzyme production to the synthesis of complex chiral intermediates and active ingredients, all based on selectAZymeTM technology.
Contract Research & Services > Contract Research > Case Studies
View all Contract Research news or find news targeted to your interests